{"id":"W3010126769","doi":"10.1007/s00134-020-05985-9","title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","year":2020,"lang":"en","type":"article","venue":"Intensive Care Medicine","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2822,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Artificial Intelligence in Medicine (Canada); University of Toronto; St. Michael's Hospital","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; Guangzhou Regenerative Medicine and Health Guangdong Laboratory; National Natural Science Foundation of China; National Science Foundation","keywords":"Medicine; Angiotensin-converting enzyme 2; Peptidyl-Dipeptidase A; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pain medicine; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Anesthesiology; Angiotensin-converting enzyme; Renin–angiotensin system; Receptor; Enzyme; Pharmacology; Internal medicine; Virology; Anesthesia; Blood pressure; Biochemistry; Disease; Biology; Infectious disease (medical specialty)","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}